In ZYX Change Method, every trade must pass through six screens. In the first Change Screen, we are looking for macro changes. In this case, our long time readers know that we have ...
AS PER THE PRIOR POST, ADDED TO $MDT SHORT AT $46.00
www.thearorareport.com
THE ARORA REPORT, Ltd.
HOME OF THE UNIQUE ZYX CHANGE METHOD
DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING
VERIFIABLE PERFORMANCE RECORD
Every closed trade since 2007, without exception, is included in the performance results.
Number of ...
SHORT SELL $STJ AND $MDT, BUY $BSX
$BSX is down substantially on FDA issues and competitors $MDT and $STJ have spiked up. These are minor paperwork issues and will not have a long term impact. Scale in on $BSX on dips. Scale ...
UPDATE ON OPEN INDIVIDUAL STOCK POSITIONS
We are exiting $BCRX and $AVAV; please see separate posts for the reasons.We are short on $ACOR with average price of $30.28. Our thesis has not changed in that Ampyra is not a very good ...
AGRESSIVELY ADDED TO SHORT POSITION ON $MDT (MEDTRONICS) AT $43.60
$MDT (Medtronics) earnings were better than expected, however a review of the earnings report does not change our medium term thesis. Unless our methodology tells us otherwise, we will use spikes up to add ...
$BSX (BOSTON SCIENTIFIC) EARNINGS CONFIRM OUR SHORT SELL THESIS
We have been short on $MDT (Medtronics) with the first scale in at $36.20 and more aggressive entry at $38.00. $BSX earnings show weakness in both stents and implantable cardiac devices. Going forward ...
CONSIDER SHORT SELL ON MDT (MEDTRONICS)
Consider start scaling in a short position in MDT right here at $36.20. MDT had passed all of our screens for a short sale, but we had been waiting for a trigger that the market ...
CHECK OUR PERFORMANCE
